Exosomes in brain diseases: Pathogenesis and therapeutic targets
MedComm · 2023-06 · 4 (3)
DOI: 10.1002/mco2.287 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift MedComm, online erschienen am 11.06.2023. Verfasst von Qingying Si und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology Tengzhou Central People's Hospital Tengzhou China. Die Arbeit wurde bisher 57-mal zitiert (Crossref) und nennt 320 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shandong Province, Taishan Scholar Project of Shandong Province.
Abstract (Originalsprache)
Exosomes are extracellular vesicles with diameters of about 100 nm that are naturally secreted by cells into body fluids. They are derived from endosomes and are wrapped in lipid membranes. Exosomes are involved in intracellular metabolism and intercellular communication. They contain nucleic acids, proteins, lipids, and metabolites from the cell microenvironment and cytoplasm. The contents of exosomes can reflect their cells’ origin and allow the observation of tissue changes and cell states under disease conditions. Naturally derived exosomes have specific biomolecules that act as the “fingerprint” of the parent cells, and the contents changed under pathological conditions can be used as biomarkers for disease diagnosis. Exosomes have low immunogenicity, are small in size, and can cross the blood–brain barrier. These characteristics make exosomes unique as engineering carriers. They can incorporate therapeutic drugs and achieve targeted drug delivery. Exosomes as carriers for targeted disease therapy are still in their infancy, but exosome engineering provides a new perspective for cell‐free disease therapy. This review discussed exosomes and their relationship with the occurrence and treatment of some neuropsychiatric diseases. In addition, future applications of exosomes in the diagnosis and treatment of neuropsychiatric disorders were evaluated in this review.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Endocrinology Tengzhou Central People's Hospital Tengzhou China.
- Department of Oncology Tengzhou Central People's Hospital Tengzhou China.
- Translational Pharmaceutical Laboratory Jining First People's Hospital Shandong First Medical University Jining China.
- Institute of Translational Pharmacy Jining Medical Research Academy Jining China.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Shandong Province
- Taishan Scholar Project of Shandong Province
- China International Medical Foundation
Zitieren
APA
Si, Q., Wu, L., Pang, D., & Jiang, P. (2023). Exosomes in brain diseases: Pathogenesis and therapeutic targets. MedComm, 4(3). https://doi.org/10.1002/mco2.287
Vancouver
Si Q, Wu L, Pang D, Jiang P. Exosomes in brain diseases: Pathogenesis and therapeutic targets. MedComm. 2023;4(3). doi:10.1002/mco2.287
BibTeX
@article{Si2023,
author = {Si, Qingying and Wu, Linlin and Pang, Deshui and Jiang, Pei},
title = {Exosomes in brain diseases: Pathogenesis and therapeutic targets},
journal = {MedComm},
year = {2023},
volume = {4},
number = {3},
doi = {10.1002/mco2.287}
}
EUVIMED